Markets:

Overview

News

Currencies

International

Treasuries

Aspire Biopharma Holdings, Inc. - Common Stock (NQ:ASBP)

2.000 -0.210 (-9.50%)

Streaming Delayed Price Updated: 3:29 PM EST, Jan 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aspire Biopharma Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Get insights into the top gainers and losers of Wednesday's pre-market session. ↗

May 28, 2025

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 28, 2025

Via Benzinga

Aspire Biopharma Holdings, Inc., Announces First Patient Dosed in Phase 1 Clinical Trial for its Lead Program, an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

May 20, 2025

Via ACCESS Newswire

Why Pegasystems Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket ↗

May 20, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 19, 2025

Via Benzinga

Top movers in Monday's after hours session ↗

May 19, 2025

Let's have a look at what is happening on the US markets after the closing bell on Monday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 12, 2025

Via Benzinga

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference May 21

May 08, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 29, 2025

Via Benzinga

Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

April 29, 2025

Via ACCESS Newswire

Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17

April 14, 2025

Via ACCESS Newswire

Aspire Biopharma Holdings, Inc., Commences Initial Production of its Pre-Workout Performance Supplement

April 11, 2025

Via ACCESS Newswire

Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

April 09, 2025

Via ACCESS Newswire

Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice (“GMP”) Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin

March 20, 2025

Via ACCESS Newswire

Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform

March 13, 2025

Via ACCESS Newswire

Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket ↗

March 13, 2025

Via Benzinga

An Interview with the CEO: How Aspire Biopharma is Disrupting a $100 Billion Market with Sublingual Innovation

March 11, 2025

New York, New York--(Newsfile Corp. - March 11, 2025) - Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) ("Aspire" or the "Company")...

Via Newsfile

Aspire Biopharma Holdings, Inc., to Launch the Next Generation of Pre-Workout Performance Supplement

March 03, 2025

Via ACCESS Newswire

Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin

February 25, 2025

Via ACCESS Newswire

Dow Tumbles Over 700 Points; US Services PMI Falls In February ↗

February 21, 2025

Via Benzinga

Topics Stocks

Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement

February 20, 2025

Via ACCESS Newswire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.